A new study published by the Annenberg Science and Public Health (ASAPH) Knowledge Monitor discovers that Americans trust the COVID-19 vaccines less now than they did right after the vaccine rollout in 2021. They also underestimate the risk of getting COVID-19 more than before. ASAPH is a project of the Annenberg Public Policy Center (APPC) …
According to the CDC’s COVID-19 virus surveillance system, a new variant of the SARS-CoV-2 virus called KP.3.1.1 has become increasingly dominant in the U.S. The strain emerged at the end of May 2024 and is currently estimated to account for 42.2% of all COVID-19 infections in the U.S. The SARS-CoV-2 KP.3.1.1 strain has evolved from …
The curtain falls on two pivotal government initiatives providing free COVID-19 tests and Paxlovid courses on March 8th. What now?
The efficacy of COVID-19 vaccines declines over time but the vaccines still have a protective effect.
Data shows that benefits outweigh risks of COVID-19 vaccinations.
Vaccines exist for RSV to prevent serious illnesses such as bronchiolitis and pneumonia. RSV vaccines reduce the risk of hospitalization from RSV.
Recognizing RSV symptoms in your little one can help keep them safe.
FDA suggests a potential association between these vaccines and a slight increase in the risk of stroke when administered alongside a high-dose flu vaccine.
CDC reveals a significant increase in burnout, anxiety, depression, and harassment among healthcare professionals, highlighting the need for support and resources.
Take a deeper look into the concept of Paxlovid rebound, its association with symptoms and testing.
Input your search keywords and press Enter.